Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism-Reference-Cited by-同舟云学术

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

Published:2010-09-08 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Erkens Petra MG,Prins Martin H

Publisher

John Wiley & Sons, Ltd

Reference78 articles.

1. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis;Belcaro;Angiology,1999

2. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis;Breddin;New England Journal of Medicine,2001

3. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy;Douketis;Archives of Internal Medicine,2000

4. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism;Cate;Journal of Vascular and Interventional Radiology,1998

5. The Columbus Investigators Low molecular weight heparin is an effective and safe treatment for deep-vein thrombosis and pulmonary embolism Blood 1996 626a

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism;Thrombosis Journal;2024-07-10

2. New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline;Neurological Research and Practice;2024-04-19

3. Evidence-Based Management of Massive and Submassive Pulmonary Embolism;JAP Academy Journal;2024-03-26

4. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association;Stroke;2024-03

5. Risk Stratification and Management of Intermediate-Risk Acute Pulmonary Embolism;Journal of Clinical Medicine;2024-01-02